COX CARRIE SMITH - Director at Cartesian Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director
Issuer Symbol
RNAC on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by COX CARRIE SMITH since 05 Jan 2025

Holdings reported by COX CARRIE SMITH for Cartesian Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 15,629 $51,576 $3.30 02 Jan 2025 Direct
Stock Option (Right to Buy) 8,000 $6,320 $0.7900 02 Jan 2025 Direct Common Stock

Transactions reported by COX CARRIE SMITH for Cartesian Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.